Symposium Article
Interspecies Scaling of Regional Drug Delivery

https://doi.org/10.1002/jps.2600751106Get rights and content

Abstract

Calculation of the pharmacokinetic advantage of regional drug administration requires knowledge of the relevant intercompartment transport parameter. In a lumped model this is the blood (or plasma) flow rate for intra-arterial drug infusion or the permeability-area product for intraperitoneal or intrathecal administration. It is suggested that the perfusion of many tissues and the intrinsic permeability of the peritoneal surface or the brain-cerebrospinal fluid interface are similar among mammals. This provides a clear allometric basis for interspecies scaling based on organ size or surface areas. Intra-arterial or intrathecal treatment of the brain or meninges is a particularly interesting problem because of the relatively large brain of humans and because increased folding results in a cortical surface area that is almost proportional to brain size. Major unresolved issues remain concerning the distributed character of the processes such as streaming of drug infused into an artery and nonuniform mixing of cerebrospinal fluid.

References and Notes (31)

  • M.J. Esperanca et al.

    J. Ped. Surg.

    (1966)
  • S.I. Rapoport et al.

    Brain. Res.

    (1979)
  • J.M. Collins et al.

    J. Pharm. Sci.

    (1982)
  • W.W. Eckman et al.

    J. Pharmacokinet. Biopharm.

    (1974)
  • J.D. Fenstermacher et al.

    Cancer Treat. Rep.

    (1977)
  • H. G. -S. Chen et al.

    Cancer Treat. Rep.

    (1980)
  • R.L. Dedrick et al.

    Cancer Treat. Rep.

    (1984)
  • R.L. Dedrick et al.

    Cancer Treat. Rep.

    (1978)
  • R.L. Dedrick et al.

    Am. Soc. Artificial Internal Organs J.

    (1982)
  • M.F. Flessner et al.

    Am. J. Physiol.

    (1984)
  • R.G. Blasberg et al.

    Cancer Treat. Rep.

    (1977)
  • R.L. Dedrick et al.

    J. Cancer Treat. Rep.

    (1975)
  • J.M. Collins

    J. Neuro-Oncol.

    (1983)
  • Cited by (78)

    • Intrathecal drug delivery in the era of nanomedicine

      2020, Advanced Drug Delivery Reviews
      Citation Excerpt :

      The nasal mucosa, especially, is an important route of clearance in small animals, whereas higher order species do not experience such high clearance through mucosal routes. Cortical folding – and thus cortical surface area – is also much higher in humans, which is an additional consideration for species scaling of IT drug delivery that has not yet been directly experimentally addressed [51]. In addition to lymphatic cranial CSF outflow via dural or cribriform lymphatics, spinal CSF outflow has also been observed in preventrebral lymph nodes under conditions of high volume, high pressure intrathecal or intracisternal fluid injections [43,52].

    • Subarachnoid Hemorrhage

      2018, Handbook of Neuroemergency Clinical Trials: Second Edition
    • Subarachnoid Hemorrhage

      2017, Handbook of Neuroemergency Clinical Trials
    • Vaginal drug distribution modeling

      2015, Advanced Drug Delivery Reviews
    • Intraperitoneal chemotherapy for peritoneal surface malignancy: Experience with 1,000 patients

      2014, Journal of the American College of Surgeons
      Citation Excerpt :

      Any systemic chemotherapy for intraperitoneal disease must overcome the plasma-peritoneal partition to reach molecular targets. Pharmacokinetic studies have confirmed the presence of this peritoneal-plasma partition by demonstrating that drugs delivered into the peritoneal cavity have a clearance that is inversely proportional to the square root of its molecular weight.31-33 Delivery of intraperitoneal chemotherapy can be viewed as a tool to overcome this drug resistance, as well the toxicity attendant to systemic administration.

    • A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C

      2013, Journal of Surgical Research
      Citation Excerpt :

      Early studies confirmed the presence of a peritoneal–plasma partition by demonstrating that drugs delivered into the peritoneal cavity have a clearance that is inversely proportional to the square root of its molecular weight owing to this partition. Drugs without lipophilic properties and high molecular weights have optimal pharmacokinetic profiles for intraperitoneal application [4–6]. Mitomycin C (MMC), an alkylating agent, is presently the most commonly used chemotherapeutic agent for hyperthermic intraperitoneal treatment [7].

    View all citing articles on Scopus
    View full text